Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARDIO-HEART cardioplegia trial
2024-511948-42-00Phase 4Authorised
- Sponsor
- Hospital Clínico San Carlos
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cardiac morbidity comparing Custodiol crystalloid cardioplegia with Buckberg blood cardioplegia (Cardi-Braun Mantenimiento) (2 arms). Primary endpoint: Composite clinical endpoint at 90 days. Planned start Jun 2024; status: authorised.
02
Drugs
HTK CustodiolCardi-Braun Mantenimiento
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2024-511948-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511948-42-00.